News Medical on MSN
ESMO 2025: VT3989 continues to show promising early results in patients with advanced mesothelioma
The first-in-class YAP-TEAD inhibitor VT3989 continued to be well tolerated and demonstrated notable initial antitumor ...
When students entered Tsinghua University in Beijing this year, one of the first representatives they met wasn’t a person.
Arrests, raids and protests have become daily occurrences as the presence of ICE in Chicago has drastically increased since the Department of Homeland Security launched what it dubbed "Operation ...
Kokomo: a private Fijian island that redefines paradise, spoils other resorts, and makes you wonder if real life should feel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback